Since loss of PD-L1 on CT26 cells leads to increased T cell activation and tumor rejection [44], upregulation of PD-L1 could conversely hamper T cell activation and promote tumor growth, a mechanism that could be counteracted by PD-1 inhibition. The gene discussed is CD274; the disease is neoplasm.